SOURCE: Healtheuniverse Inc.

February 13, 2007 08:56 ET

Healtheuniverse to Market and Commercialize Non-Embryonic Stem Cell Therapies Under the Brand Name Euphora

COVINA, CA -- (MARKET WIRE) -- February 13, 2007 -- Healtheuniverse Inc. (PINKSHEETS: HLUN), a diversified biotechnology development firm specializing in the development and commercialization of biopharmaceutical and biomedical products, announced today its non-embryonic stem cell therapies will be marketed and commercialized using the brand name Euphora. The first two products in the commercialization pipeline target the plastic surgery and wound care markets.

"We are accelerating and expanding development of our proprietary non-embryonic stem cell therapies while continuing to advance our other promising clinical and preclinical development programs," stated Dr. Vipul Dev, MD Chief Executive Officer of Healtheuniverse, Inc. "Our commercialization timelines and strength of clinical and pre-clinical resources can also be enhanced through strategic alliances with scientific collaborators as we push to bring the potential benefits of stem cell therapies to patients."

About HEALTHeUNIVERSE Inc.

HEALTHeUNIVERSE Inc. is a biotechnology development firm specializing in the development and commercialization of patented Biopharmaceutical and Biomedical products. We are engaged in research and development of regenerative medicine therapies using non-embryonic adult stem cells for use in plastic, reconstructive, orthopedic, vascular, and cardiac surgery. Healtheuniverse strives to be the first to commercialize the use of regenerative medicine in plastic and reconstructive surgery and to develop therapeutic uses in the most profitable commercial applications. More information on Healtheuniverse is available online at http://healtheuniverse.com/

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of Healtheuniverse Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

Contact Information

  • For more information, please contact:
    Healtheuniverse, Inc.
    Investor Relations
    800-719-7424
    Email Contact